Thanks from Global Fund Executive Director Kazatchkine

NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria, "[a]long with our partners, both donors and implementers, [is] changing the story of scores of nations that were once devastated by three killer diseases -- diseases which seemed invincible," Global Fund Executive Director Michel Kazatchkine writes in a Huffington Post opinion piece, adding "we are now saving more than one million lives every year."

He continues, "No one should be more proud of this than the people of the United States. Its leadership in global health through programs such as PEPFAR (President's Emergency Plan For AIDS Relief), PMI (President's Malaria Initiative) and of course its leading support for the Global Fund, has been a crucial catalyst for success. The millions of lives saved every year by all these programs is a return on the United States' investment in global health." Kazatchkine thanks the "inspiring individuals" who last week signed on to an open letter pledging support for the Global Fund, concluding, "We have never been so close" (9/27).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO recommends R21/Matrix-M vaccine for malaria prevention in children